Lennie Sender

The promise and limits of cancer immunotherapy

Share This Talk

TEDMED Talks are available, free to the world, thanks to our partners.

About Lennie Sender

Oncologist Leonard Sender is a pioneer in cancer care treatment, especially in adolescents and young adults, which are typically underrepresented cohorts in the oncological research. Lennie is Director of the Adolescent and Young Adult (AYA) Cancer Program at CHOC Children’s Hospital in Orange County, where he leads one of the nation’s largest programs considering the unique challenges faced by AYA cancer patients, such as preservation of fertility, management of the effects of treatment, and the psychosocial impact of the disease. As an innovative leader in research, Lennie is conducting extensive studies to improve outcomes and quality of life for AYA’s. Lennie is Chairman Emeritus of the Stupid Cancer organization and is a founding member and chairman of SeventyK.org, an advocacy site for AYA’s with cancer.

Find out more

About This Talk

Since its advent, there have been numerous conflicting reports about whether immunotherapy will be a “silver bullet” for different types of cancer, or if such expectations are based on hype or limited evidence. Many of the misconceptions about immunotherapy’s potential are due to our limited understanding of the immune system and how it serves to protect us from disease.

A pioneer in cancer care treatment, oncologist Lennie Sender has a deep understanding of both the possibilities and limitations of harnessing the immune system to treat different types of cancer. Check out Lennie’s 2017 TEDMED Talk for his straightforward report of the state of cancer immunotherapy options today and the promise they may hold for the future.

Other Talks from TEDMED 2017